WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
China to cut individual housing provident fund loan rates by 0.25 percentage pointsChina to initiate issuance of ultraMacron hosts Xi at mountain restaurant in picturesque southern FranceWolf and Bakrar each score a goal, NYCFC beats Red Bulls 2Heartbroken Lisa Armstrong was grieving family member's death as exJosé Ramírez homers, drives in 3 runs as AL Central2 shot dead on outskirts of ParisBlinken reiterates US opposition to Rafah invasionWolf and Bakrar each score a goal, NYCFC beats Red Bulls 2Chinese language proficiency contests held in Namibia